| scholarly article | Q13442814 |
| P50 | author | Benjamin M. Segal | Q42612550 |
| Stephen J. Lalor | Q47968259 | ||
| Julie M Rumble | Q84213387 | ||
| P2093 | author name string | Nilufer Esen | |
| David N. Irani | |||
| Emily K. Rainey-Barger | |||
| P2860 | cites work | B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5 | Q24309316 |
| Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice | Q27486805 | ||
| A chemokine-driven positive feedback loop organizes lymphoid follicles | Q28142202 | ||
| CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity | Q28217241 | ||
| B-cell depletion with rituximab in relapsing-remitting multiple sclerosis | Q28268626 | ||
| A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen | Q28300225 | ||
| A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis | Q29616119 | ||
| Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project | Q33383576 | ||
| The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. | Q33611768 | ||
| Development and maturation of secondary lymphoid tissues. | Q33652498 | ||
| Lymphoid chemokines in the CNS. | Q34020894 | ||
| Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice | Q34110300 | ||
| Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. | Q34191599 | ||
| Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen | Q34488105 | ||
| CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses | Q34726022 | ||
| Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression | Q34831296 | ||
| Three or more routes for leukocyte migration into the central nervous system | Q35183162 | ||
| Chemokines in the systemic organization of immunity | Q35216944 | ||
| The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity | Q35216957 | ||
| Recognition of Staphylococcus aureus-derived peptidoglycan (PGN) but not intact bacteria is mediated by CD14 in microglia | Q36647941 | ||
| BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma | Q36762885 | ||
| Lymphoid chemokines in chronic neuroinflammation | Q37186200 | ||
| CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice | Q37299504 | ||
| Rituximab-associated infections | Q37720889 | ||
| Novel lymphocyte-specific CC chemokines and their receptors. | Q41640121 | ||
| The role of antibody in recovery from alphavirus encephalitis | Q41672969 | ||
| BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. | Q41740089 | ||
| Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitis | Q42102380 | ||
| Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. | Q43227358 | ||
| CXCL13 and CXCL12 in central nervous system lymphoma patients. | Q43272851 | ||
| Characterization of the local and systemic B cell response of normal and athymic nude mice with Sindbis virus encephalitis | Q44390426 | ||
| Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. | Q44999948 | ||
| Virus specificity and isotype expression of intraparenchymal antibody-secreting cells during Sindbis virus encephalitis in mice | Q45777848 | ||
| CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. | Q46275246 | ||
| Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. | Q46655434 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. | Q48200750 | ||
| B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization | Q48364459 | ||
| Long term intraparenchymal Ig secretion after acute viral encephalitis in mice | Q48394895 | ||
| Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. | Q52022097 | ||
| Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice. | Q52539853 | ||
| Turning off follicular dendritic cells | Q59068710 | ||
| Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin β receptor-Ig fusion protein | Q60455093 | ||
| Antibody-mediated clearance of alphavirus infection from neurons | Q68262671 | ||
| B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide | Q73170385 | ||
| Recent advances in chemokines and chemokine receptors | Q78165392 | ||
| A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21 | Q80833012 | ||
| CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis | Q80880885 | ||
| CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis | Q83918246 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 922-931 | |
| P577 | publication date | 2010-10-08 | |
| P1433 | published in | Brain, Behavior, and Immunity | Q15716593 |
| P1476 | title | The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system | |
| P478 | volume | 25 |
| Q30426152 | A conceptual revolution in the relationships between the brain and immunity |
| Q40530656 | Activated GL7+ B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis. |
| Q48420893 | Altered Expression of CXCL13 and CXCR5 in Intractable Temporal Lobe Epilepsy Patients and Pilocarpine-Induced Epileptic Rats |
| Q36138217 | Astrocyte matricellular proteins that control excitatory synaptogenesis are regulated by inflammatory cytokines and correlate with paralysis severity during experimental autoimmune encephalomyelitis |
| Q36667911 | Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis |
| Q39148044 | Brain inflammation is accompanied by peripheral inflammation in Cstb (-/-) mice, a model for progressive myoclonus epilepsy. |
| Q36515088 | CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5. |
| Q36788638 | CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis |
| Q35077540 | CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis |
| Q38018862 | Chemokines in CNS injury and repair |
| Q39227824 | Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain. |
| Q64957483 | Clinical utility of a molecular signature in inflammatory demyelinating disease. |
| Q37612495 | Cocapture of cognate and bystander antigens can activate autoreactive B cells |
| Q57810320 | Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis |
| Q36476035 | Endogenous adaptation to low oxygen modulates T-cell regulatory pathways in EAE. |
| Q47232442 | GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction |
| Q48966537 | Gaucher disease: chemotactic factors and immunological cell invasion in a mouse model |
| Q36919822 | Glial cell activation, recruitment, and survival of B-lineage cells following MCMV brain infection |
| Q92339537 | Induction of brain-infiltrating T-bet-expressing B cells in multiple sclerosis |
| Q59350636 | Interferon regulatory factors 3 and 7 have distinct roles in the pathogenesis of alphavirus encephalomyelitis |
| Q38084075 | Intrathecal humoral immunity to encephalitic RNA viruses. |
| Q37592155 | Knockout of CXCR5 increases the population of immature neural cells and decreases proliferation in the hippocampal dentate gyrus. |
| Q52145462 | Lack of NG2 exacerbates neurological outcome and modulates glial responses after traumatic brain injury. |
| Q92313351 | Neopterin and CXCL-13 in Diagnosis and Follow-Up of Trypanosoma brucei gambiense Sleeping Sickness: Lessons from the Field in Angola |
| Q36578354 | New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients |
| Q41933450 | Protective Humoral Immunity in the CNS Requires Peripheral CD19-Dependent Germinal Center Formation Following Coronavirus Encephalomyelitis. |
| Q36607157 | Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis |
| Q33772300 | Regulated Production of CXCL13 within the Central Nervous System |
| Q57825775 | Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis |
| Q36551188 | Targeting CXCL13 During Neuroinflammation |
| Q34083294 | Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. |
| Q36117017 | Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis |
Search more.